Eli Lilly’s New Obesity Drug Shows Powerful Weight Loss, But Side Effects Raise Concerns
Eli Lilly has reported impressive results from a large Phase 3 clinical trial of its experimental obesity drug, retatrutide. The drug helped patients lose significantly more weight than expected and also reduced knee pain linked to osteoarthritis. However, some patients stopped treatment due to side effects, raising questions about how well people can tolerate the
